← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2008Last known activity
Oct 13, 2025
Timeline
1920s
- Jun 1, 1921
Sutter Health— Founded
Drugs by trial phase (13 distinct, 13 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Anemia, Iron-Deficiency
- Autism Spectrum Disorder
- Autistic Disorder
- Blepharoptosis
- Breast Neoplasms
- Carcinoma
- Cognitive Dysfunction
- Compartment Syndromes
- Esotropia
- Exotropia
- Fractures, Bone
- Fractures, Stress
- Glioblastoma
- Graves Disease
- Heart Failure
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Nasopharyngeal Carcinoma
- Penile Induration
- Recurrence
- Strabismus
- Syndrome
- Triple Negative Breast Neoplasms
- Uveitis
Recent trials (32)
- NCT07237100Lead sponsorPhase 2Oct 13, 2025
- NCT07237100Sponsor investigatorPhase 2Oct 13, 2025
- NCT06706752Sponsor investigatorPhase 2Dec 31, 2024
- NCT06706752Lead sponsorPhase 2Dec 31, 2024
- NCT04092647Study directorPhase 2Jan 1, 2020
- NCT04092647Lead sponsorPhase 2Jan 1, 2020
- NCT04092647Reponsible party - principal investigatorPhase 2Jan 1, 2020
- NCT04092647Overall official - principal investigatorPhase 2Jan 1, 2020
- NCT04027478Study directorN/ASep 1, 2019
- NCT04027478Lead sponsorN/ASep 1, 2019
- NCT04027478Reponsible party - principal investigatorN/ASep 1, 2019
- NCT04027478Overall official - principal investigatorN/ASep 1, 2019
- NCT03319810Study directorPhase 2Jan 4, 2018
- NCT03319810Reponsible party - principal investigatorPhase 2Jan 4, 2018
- NCT03319810Lead sponsorPhase 2Jan 4, 2018
Details
- Founded
- Sacramento, CA, US Jun 1, 1921
- Last known activity
- Oct 13, 2025